A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database

References

• Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–1564.
   PubMed Web of Science ®Google Scholar
• Avery AA, Barber N, Ghaleb M, et al. Investigating the prevalence and causes of prescribing errors in general practice: the practice study. General Medical Council; May 2 2012 [cited 2018 May 29]. Available from: https://www.gmc-uk.org/-/media/about/investigatingtheprevalenceandcausesofprescribingerrorsingeneralpracticethepracticestudyreoprtmay2012.pdf?la=en&hash=62C1821CA5CCC5A4868B86A83FEDE14283686C29
   Google Scholar
• Avery AJ, Ghaleb M, Barber N, et al. The prevalence and nature of prescribing and monitoring errors in English general practice: a retrospective case note review. Br J Gen Pract. 2013;63(613):E543–E553.
   PubMed Web of Science ®Google Scholar
• World Health Organization. World alliance for patient safety: WHO draft guidelines for adverse event reporting and learning systems: from information to action. Geneva: World Health Organization; 2005 [cited 2018 May 29]. Available from: http://www.who.int/iris/handle/10665/69797
   Google Scholar
• Xu JQ, Murphy SL, Kochanek KD, et al. Deaths: final data for 2013. Natl Vital Stat Rep. 2015;64:2.
   Google Scholar
• Goedecke T, Ord K, Newbould V, et al. Medication errors: new EU good practice guide on risk minimisation and error prevention. Drug Saf. 2016;39(6):491–500.
   PubMed Web of Science ®Google Scholar
• Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA. 1997;277(4):307–311.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pharmaceuticals newsletter. Extending the scope of pharmacovigilance centres. Nr. 6; 2007 [cited 2018 May 29]. Available from: http://www.who.int/medicines/publications/newsletter/PN_No6_2007.pdf
   Google Scholar
• Bencheikh RS, Benabdallah G. Medication errors: pharmacovigilance centres in detection and prevention. Br J Clin Pharmacol. 2009;67(6):687–690.
   PubMed Web of Science ®Google Scholar
• Uppsala Monitoring Centre. Reporting statistics. Uppsala reports. Nr. 59; 2010 [cited 2018 May 28]. Available from: https://www.who-umc.org/media/164362/ur59_web.pdf
   Google Scholar
• Newbould V, Le Meur S, Goedecke T, et al. Medication errors: a characterisation of spontaneously reported cases in eudravigilance. Drug Saf. 2017 Dec;40(12):1241–1248.
   PubMed Web of Science ®Google Scholar
• Alj L, Benkirane R, Soulaymani R. Detecting medication errors in pharmacovigilance database: capacities and limits. Int J Risk Saf Med. 2007;19:1–8.
   Google Scholar
• Jonville-Bera AP, Saissi H, Bensouda-Grimaldi L, et al. Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre. Drug Saf. 2009;32(5):429–440.
   PubMed Web of Science ®Google Scholar
• Kunac DL, Tatley MV. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis. Drug Saf. 2011;34(1):59–71.
   PubMed Web of Science ®Google Scholar
• Machado Alba JE, Moreno Gutierrez PA, Moncada Escobar JC. Hospital medication errors in a pharmacovigilance system in Colombia. Farm Hosp. 2015;39(6):338–343.
   PubMedGoogle Scholar
• Rishoej RM, Almarsdottir AB, Christesen HT, et al. Medication errors in pediatric inpatients: a study based on a national mandatory reporting system. Eur J Pediatr. 2017;176(12):1697–1705.
   PubMed Web of Science ®Google Scholar
• Cohen MR. Medication errors: causes, prevention, and risk management. Sudbury, M.A: Jones & Bartlett Publishers; 1999.
   Google Scholar
• Almenoff JS, Pattishall EN, Gibbs TG, et al. Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther. 2007;82(2):157–166.
   PubMed Web of Science ®Google Scholar
• Rishoej RM, Thybo Christesen H, Juel Kjeldsen L, et al. Disproportionality Analysis Used to Identify Patterns in Medication Error Reports Involving Hospitalized Children. Basic Clin Pharmacol Toxicol. 2018;122(5):531–533.
   PubMed Web of Science ®Google Scholar
• Hansen RA, Cornell PY, Ryan PB, et al. Patterns in nursing home medication errors: disproportionality analysis as a novel method to identify quality improvement opportunities. Pharmacoepidemiol Drug Saf. 2010;19(10):1087–1094.
   PubMed Web of Science ®Google Scholar
• International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Medical dictionary for regulatory activities (MedDRA®). Standardised MedDRA® Queries; [cited 2018 Jan 12]. Available from: https://www.meddra.org/standardised-meddra-queries
   Google Scholar
• Kass-Hout TA, Xu Z, Mohebbi M, et al. OpenFDA: an innovative platform providing access to a wealth of FDA’s publicly available data. J Am Med Inform Assoc. 2016;23(3):596–600.
   PubMed Web of Science ®Google Scholar
• FDA/OpenFDA. GitHub, Inc; 2015 [cited 2018 Mar 11]. Available from: https://github.com/FDA/openfda
   Google Scholar
• U.S. Food and Drug Administration. OpenFDA. Drug Adverse Events [/drug/event]; [cited 2018 Mar 12]. Available from: https://open.fda.gov/tools/downloads/
   Google Scholar
• Institute of Medicine. Preventing medication errors: quality chasm series. Washington, DC: National Academies Press; 2006.
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 2000. ICH M2 EWG electronic transmission of individual case safety reports message specification. Version 2.3. Geneva ICH Secretariat; [cited 2018 Mar 18]. Available from: http://estri.ich.org/e2br22/ICH_ICSR_Specification_V2-3.pdf
   Google Scholar
• Morris T, Guidry T, Magdinie M. Openrefine: a free, open source, powerful tool for working with messy data. Tech. Rep. The OpenRefine Development Team; 2015.
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs, 2008. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2009.
   Google Scholar
• International Conference on Harmonisation of Technical Requirement for Registration of Pharmacautical for Human Use (ICH). Clinical investigation of medicinal products in the paediatric population. Guide to Paediatric Clinical Research, E 11; 2000 [cited 2018 Mar 10]. Available from: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E11/Step4/E11_Guideline.pdf
   Google Scholar
• Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483–486.
   PubMed Web of Science ®Google Scholar
• Van Puijenbroek EP, Bate A, Leufkens HG, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(1):3–10.
   PubMed Web of Science ®Google Scholar
• Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54(4):315–321.
   PubMed Web of Science ®Google Scholar
• Fridén S, Star K, Noren N. Gender distribution in international adverse drug reaction surveillance [abstract nr 127]. Drug Saf. 2009;32(10):929.
   Web of Science ®Google Scholar
• Van Grootheest K, de Graaf L, de Jong-van den Berg LT. Consumer adverse drug reaction reporting: a new step in pharmacovigilance? Drug Saf. 2003;26(4):211–217.
   PubMed Web of Science ®Google Scholar
• Behm C. ‘The role of the patient in pharmacovigilance-TGA perspective’ [power point presentation] 2017 ARCS Annual Conference; 2017 [cited 2018 Jul 19]. Available from: https://www.tga.gov.au/sites/default/files/presentation-role-patient-pharmacovigilance.pdf
   Google Scholar
• Olsson S. Patient reporting is the future of pharmacovigilance. Uppsala Reports Opinion; 2017 October [cited 2018 Jul 19]. Available from: https://www.who-umc.org/archive/patient-reporting-is-the-future-of-pharmacovigilance/
   Google Scholar
• Toki T, Ono S. Spontaneous reporting on adverse events by consumers in the United States: an analysis of the food and drug administration adverse event reporting system database. Drugs Real World Outcomes. 2018;5(2):117–128.
   PubMedGoogle Scholar
• Neuspiel DR, Taylor MM. Reducing the risk of harm from medication errors in children. Health Serv Insights. 2013;6:47–59.
   PubMedGoogle Scholar
• Zakharov S, Tomas N, Pelclova D. Medication errors-an enduring problem for children and elderly patients. Ups J Med Sci. 2012;117(3):309–317.
   PubMed Web of Science ®Google Scholar
• Tzimenatos L, Bond GR. Severe injury or death in young children from therapeutic errors: a summary of 238 cases from the American association of poison control centers. Clin Toxicol (Phila). 2009;47(4):348–354.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Adler LA, Adams J, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47:21–31.
   PubMed Web of Science ®Google Scholar
• Dunlop AJ, Newman LK. ADHD and psychostimulants - overdiagnosis and overprescription. Med J Aust. 2016 Mar 7;204(4):139.
   PubMed Web of Science ®Google Scholar
• Boland F, Galvin R, Reulbach U. Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study. BMC Pediatr. 2015 Sep;10(15):118.
   Google Scholar
• Guerin A, Mody R, Carter V, et al. Changes in practice patterns of Clopidogrel in combination with proton pump inhibitors after an FDA safety communication. PloS one. 2016;11(1):e0145504.
   PubMed Web of Science ®Google Scholar
• Anderson SL, Vande Griend JP. Quetiapine for insomnia: a review of the literature. Am J Health Syst Pharm. 2014;71(5):394–402.
   PubMed Web of Science ®Google Scholar
• QuarterWatch™ (2016 Quarter 1 Data): Lessons Learned from Withdrawal of the Zecuity Patch. Patient difficulties using the Tanzeum pen. Philadelphia, PA: Institute for Safe Medication Practices; 2016.
   Google Scholar
• Prescrire Editorial Staff. Insulin use: preventable errors. Prescrire Int. 2014;23(145):14–17.
   PubMedGoogle Scholar
• Flynn EA, Barker KN, Berger BA, et al. Dispensing errors and counseling quality in 100 pharmacies. J Am Pharm Assoc. 2009;49(2):171–182.
   Google Scholar
• Page MD, Stephenson C, Pope RM, et al. Prescribing and dispensing of insulin: margins for error? Diabet Med. 1992;9(10):938–941.
   PubMed Web of Science ®Google Scholar
• Sircar M, Bhatia A, Munshi M. Review of hypoglycemia in the older adult: clinical implications and management. Can J Diabetes. 2016;40(1):66–72.
   PubMed Web of Science ®Google Scholar
• Safeguard against errors with long-acting oral narcotics. ISMP Can Saf Bull. 2003;3(9):1–2.
   Google Scholar
• Medication errors linked to drug name confusion. PA PSRS Patient Saf Advis. 2004 Dec;1(4):7–8. Available from: http://patientsafety.pa.gov/ADVISORIES/Pages/200412_07.aspx
   Google Scholar
• QuarterWatch™ (Quarter 3 2017): emerging Risks with inhaled medications using the Ellipta device, the controversy with antidepressants, and loperamide abuse. Philadelphia, PA: Institute for Safe Medication Practices website; 2015.
   Google Scholar
• Aldhwaihi K, Schifano F, Pezzolesi C, et al. A systematic review of the nature of dispensing errors in hospital pharmacies. Integr Pharm Res Pract. 2016;5:1–10.
   PubMed Web of Science ®Google Scholar